Macroview Investment Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-28
Closed -$536 388
2024
Q3
$536 Hold
28
﹤0.01% 536
2024
Q2
$580 Hold
28
﹤0.01% 533
2024
Q1
$527 Hold
28
﹤0.01% 592
2023
Q4
$404 Sell
28
-283
-91% -$3.85K ﹤0.01% 582
2023
Q3
$5.4K Buy
311
+283
+1,011% +$5.9K 0.01% 407
2023
Q2
$583 Sell
28
-9
-24% -$196 ﹤0.01% 445
2023
Q1
$871 Hold
37
﹤0.01% 385
2022
Q4
$1.03K Hold
37
﹤0.01% 392
2022
Q3
$1K Hold
37
﹤0.01% 380
2022
Q2
$1K Buy
37
+9
+32% +$315 ﹤0.01% 412
2022
Q1
$1K Hold
28
﹤0.01% 398
2021
Q4
$1K Hold
28
﹤0.01% 365
2021
Q3
$1K Hold
28
﹤0.01% 354
2021
Q2
$1K Buy
+28
New +$922 ﹤0.01% 378

Other funds holding OGN

Macroview Investment Management's OGN Position: Q4 2024 in Review

Macroview Investment Management sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 28 shares — an estimated $536 sold.

Macroview Investment Management first reported a position in OGN in Q2 2021 and held it in 14 quarters. The position peaked at $5.4K in Q3 2023. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Macroview Investment Management reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • Macroview Investment Management sold 28 Organon & Co shares in Q4 2024, an estimated $536.
  • Macroview Investment Management first reported a position in Organon & Co in Q2 2021 and held it in 14 quarters.
  • Macroview Investment Management's Organon & Co position peaked at $5.4K in Q3 2023.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.